The world's first AI-driven, ethically integrated biospecimen marketplace. Unlocking India’s vast, treatment-naïve patient populations for global precision medicine.
"We don't just export samples. We import care."
Social Enterprise Model
~20% of proceeds fund patient treatment
Our ecosystem combines robust physical infrastructure, advanced AI intelligence, and an unwavering ethical engine.
Powered by myOnsite. Leveraging 16+ years of US-standard logistics. Our W-2 employed mobile workforce reaches Tier-2/3 cities for home-based collection with strict cold-chain custody.
Powered by MedinovAI. A zero-human-in-the-loop ecosystem. Our TrialMatchAI engine scans millions of data points to identify high-value cohorts instantly.
Real-time Data Integrity Active
Social Enterprise Model. We create a sustainable cycle of value. Revenue is funneled back to partner hospitals to subsidize care for the indigent patients fueling research.
Access high-quality, annotated biospecimens that are scarce in Western biobanks but abundant in our network. Focus on Oral, Cervical, Gallbladder, and TNBC.
TNBC, Oral SCC, Gallbladder. <1hr Ischemia.
Tumor + Normal + Blood (PBMC/Plasma).
Pre & Post treatment (e.g. EGFR T790M+).
Deep clinical annotation. Colorectal MSI-H.
Global Scarcity vs. India Supply Capability
President & CEO, myOnsite Healthcare
25+ years of leadership in healthcare IT and services. Expert in spotting market opportunities and establishing nationwide networks in the US.
Director, DescartesBio.in
The Bridge connecting academic and medical institutions with global operations. Committed to reinvesting resources into patient well-being.
Trusted by Premier Institutions & Networks
From the patient's arm to your lab, every step is tracked, verified, and secured by blockchain technology.
Patient matched via EMR integration using our proprietary TrialMatchAI. Identifies treatment-naïve cohorts instantly.
Digital, compliant consent on mobile. Smart dispatch of myOnsite phlebotomists to patient homes.
Blockchain-backed tracking. Temperature monitoring from point of collection. Processing & QC within 4 hours.
Automated ICMR/NOC filing via THBM Portal. IATA UN3373 packaging for seamless export.
Traditional global trials are plagued by delays and data gaps. Our integrated model changes the equation.
"Case Study: Accelerating Biomarker Research. Completed 33% faster with 22% cost savings."
Guided by the UN's "Leave No One Behind" principle. We ensure that the cure for cancer begins with care for the patient today.
Subsidizing Diagnostics & Treatment